RxDoctor Payments Data

Jonathan Wolfe, MD

Interventional Cardiology · Pittsburgh, PANPI 1598176620

Payments from drug & device makers

$9,381in general payments, 2019–2025

Across 72 payments — averaging $130.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Boston Scientific$1K
  • Philips North America LLC$806
  • Abiomed$780
  • Cardiovascular Systems Inc.$451
  • Abbott$374
  • plus $2K from 17 others

What the payments were for

  • Grants$2725%
  • Travel & lodging$57510%
  • Food & beverage$4,99786%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,381 in reported general payments places this provider in the 50th percentile of 281 interventional cardiology providers in Pennsylvania.

See all interventional cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$41,443
Medicare patients
90
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan23$20,239
JardianceEmpagliflozin20$19,623
Rosuvastatin Calcium29$477
ClopidogrelClopidogrel Bisulfate32$173
Metoprolol Succinate18$128
Atorvastatin Calcium13$58

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →